(2S,3R,4S)-2-methyl-3,4-dihydro-2H-pyran-3,4-diol → 1,5 anhydro-2,6-dideoxy-L-erythro-hex-1-en-3-ulose

HRID 1648804Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1648804
[CH3:1][C@@H:2]1[O:7][CH:6]=[CH:5][C@H:4]([OH:8])[C@H:3]1[OH:9]>C1C=CC=CC=1.C([O-])([O-])=O.[Ag+].[Ag+]>[CH:6]1[O:7][C@@H:2]([CH3:1])[C@H:3]([OH:9])[C:4](=[O:8])[CH:5]=1

Komponenten

4

Edukt 1

HCID 10986248(2S,3R,4S)-2-methyl-3,4-dihydro-2H-pyran-3,4-diol2×

Produkt 1

HCID 109424341,5 anhydro-2,6-dideoxy-L-erythro-hex-1-en-3-ulose

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 92796Silver carbonateKatalysator2×HCID 241BenzeneLösungsmittel

Versuchsvorschrift

When Fetizon's reagent is used, L-rhamnal is dissolved in benzene and then the Fetizon's reagent is added to the mixture (20 g reagent: 1 g L-rhamnal). The mixture is refluxed for 1 hour, the spent reagent removed by filtration, and the solvent removed by evaporation to yield nearly pure enone. When the oxidant is chromium trioxide:pyridine complex, L-rhamnal is added to a solution of the oxidant in dichloromethane followed by addition of 4 equivalents of acetic anhydride. After 20 minutes the reaction mixture is poured onto a column of silica gel (ethyl acetate eluent) containing excess ethyl acetate at the top to precipitate insoluble chromium compounds. The product is eluted with ethyl acetate. If manganese dioxide is used, L-rhamnal is dissolved in tetrahydrofuran and treated with active manganese dioxide (15 g MnO2 : 1 g L-rhamnal) and stirred at room temperature for 2-3 days. The oxidant is then removed by filtration and the product purified by chromatography on a silica gel column (ethyl acetate eluent).

Aufarbeitung

  1. temperatureThe mixture is refluxed for 1 hour
  2. customthe spent reagent removed by filtration
  3. customthe solvent removed by evaporation

Quellen und Nachweise

ORD-Eintrag
ord-a88d6a35e59946c299bc2ba98c5d0ba4
Quelldatensatz
uspto-grants-1983_11
Patentnummer
US04413120

Notizen zur Reaktion

Wird geladen…